FSMAX
Price
$77.84
Change
-$0.00 (-0.00%)
Updated
Apr 22, 6:59 PM EST
IAXTX
Price
$8.52
Change
-$0.00 (-0.00%)
Updated
Apr 22, 6:59 PM EST
Ad is loading...

Analysis and predictions FSMAX vs IAXTX

Header iconFSMAX vs IAXTX Comparison
Open Charts FSMAX vs IAXTXBanner chart's image
Fidelity Extended Market Index
Price$77.84
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
VY® T. Rowe Price Divers Mid Cap Gr S2
Price$8.52
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSMAX vs IAXTX Comparison Chart

Loading...

VS
FSMAX vs. IAXTX commentary
Apr 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Sell and IAXTX is a Hold.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.8B vs. IAXTX (1.03B). FSMAX pays higher dividends than IAXTX: FSMAX (1.10) vs IAXTX (0.00). FSMAX was incepted earlier than IAXTX: FSMAX (13 years) vs IAXTX (15 years). IAXTX is a more actively managed with annual turnover of: 45.00 vs. FSMAX (18.00). FSMAX (0) and IAXTX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 19.43 vs. IAXTX (15.60). FSMAX return over 5 years is better than : 30.63 vs. IAXTX (1.59).
FSMAXIAXTXFSMAX / IAXTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years15 years-
Gain YTD-0.2823.776-7%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets39.8B1.03B3,849%
Annual Yield % from dividends1.100.00-
Returns for 1 year19.4315.60124%
Returns for 3 years-9.21-28.2333%
Returns for 5 years30.631.591,924%
Returns for 10 years62.6578.7280%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDSB2.990.35
+13.04%
PDS Biotechnology Corp
ALV117.282.45
+2.13%
Autoliv
GERN3.730.04
+1.08%
Geron Corp
ATXS9.800.05
+0.51%
Astria Therapeutics
ZVSA0.57-0.01
-1.91%
ZyVersa Therapeutics